
Docon Technologies Pvt Ltd, a 100 percent subsidiary of PharmEasy’s parent firm API, will be the acquirer and shall make an open offer for an additional 26 percent stake. Read More
reported by at Moneycontrol
Docon Technologies Pvt Ltd, a 100 percent subsidiary of PharmEasy’s parent firm API, will be the acquirer and shall make an open offer for an additional 26 percent stake. Read More
reported by at Moneycontrol
Recent Comments